Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · IEX Real-Time Price · USD
76.12
+0.71 (0.94%)
At close: Jul 2, 2024, 4:00 PM
76.08
-0.04 (-0.05%)
After-hours: Jul 2, 2024, 7:49 PM EDT

Dr. Reddy's Laboratories Revenue

In the fiscal year ending March 31, 2024, Dr. Reddy's Laboratories had annual revenue of $3.35B with 11.97% growth.

Revenue (ttm)
$3.35B
Revenue Growth
+11.97%
P/S Ratio
3.78
Revenue / Employee
$129,502
Employees
25,863
Market Cap
12.68B USD

Revenue Chart

* The company reports in INR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 20243.35B358.07M11.97%
Mar 31, 20232.99B177.70M6.32%
Mar 31, 20222.81B228.76M8.85%
Mar 31, 20212.58B269.12M11.62%
Mar 31, 20202.32B92.37M4.15%
Mar 31, 20192.22B41.59M1.91%
Mar 31, 20182.18B13.23M0.61%
Mar 31, 20172.17B-165.41M-7.09%
Mar 31, 20162.33B-33.74M-1.42%
Mar 31, 20152.37B159.80M7.24%
Mar 31, 20142.21B67.36M3.15%
Mar 31, 20132.14B232.69M12.20%
Mar 31, 20121.91B231.71M13.82%
Mar 31, 20111.68B111.29M7.11%
Mar 31, 20101.56B196.93M14.40%
Mar 31, 20091.37B118.18M9.46%
Mar 31, 20081.25B-252.03M-16.78%
Mar 31, 20071.50B956.82M175.61%
Mar 31, 2006544.85M97.83M21.89%
Mar 31, 2005447.02M-16.09M-3.47%
Mar 31, 2004463.11M83.73M22.07%
Mar 31, 2003379.39M38.58M11.32%
Mar 31, 2002340.80M104.68M44.33%
Mar 31, 2001236.13M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fresenius Medical Care AG & Co. KGaA 21.17B
Tenet Healthcare 20.91B
Viatris 15.36B
DaVita 12.34B
Incyte 3.77B
Revvity 2.73B
Royalty Pharma 2.24B
Medpace Holdings 1.96B
Revenue Rankings